ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05167	Kaposi's sarcoma-associated herpesvirus infection	11/45	191/7206	1.57325862405e-08
ko04668	TNF signaling pathway	9/45	120/7206	3.90055484295e-08
ko04380	Osteoclast differentiation	9/45	134/7206	1.0209495004e-07
ko05160	Hepatitis C	9/45	153/7206	3.1970645289e-07
ko04621	NOD-like receptor signaling pathway	9/45	157/7206	3.98474590629e-07
ko04217	Necroptosis	9/45	178/7206	1.15236233473e-06
ko04060	Cytokine-cytokine receptor interaction	9/45	191/7206	2.07709942767e-06
ko05145	Toxoplasmosis	7/45	126/7206	1.10481525652e-05
ko04210	Apoptosis	8/45	180/7206	1.26872738867e-05
ko05168	Herpes simplex infection	8/45	182/7206	1.37563080247e-05
ko05152	Tuberculosis	8/45	187/7206	1.67666184182e-05
ko04064	NF-kappa B signaling pathway	6/45	96/7206	2.55861060857e-05
ko04620	Toll-like receptor signaling pathway	6/45	100/7206	3.22923063014e-05
ko04622	RIG-I-like receptor signaling pathway	5/45	62/7206	3.75378923085e-05
ko05161	Hepatitis B	7/45	173/7206	8.55469658549e-05
ko05162	Measles	6/45	120/7206	9.01419238496e-05
ko04630	Jak-STAT signaling pathway	6/45	132/7206	0.000152779534827
ko04917	Prolactin signaling pathway	5/45	87/7206	0.00019090022872
ko04662	B cell receptor signaling pathway	5/45	88/7206	0.000201464981392
ko04062	Chemokine signaling pathway	7/45	201/7206	0.000218299660123
ko05169	Epstein-Barr virus infection	7/45	206/7206	0.000253946583
ko05203	Viral carcinogenesis	8/45	277/7206	0.000268976016091
ko05321	Inflammatory bowel disease (IBD)	4/45	56/7206	0.000384680937153
ko05164	Influenza A	6/45	167/7206	0.000545301456772
ko04933	AGE-RAGE signaling pathway in diabetic complications	5/45	135/7206	0.00143440565767
ko04931	Insulin resistance	5/45	137/7206	0.00153133441195
ko05212	Pancreatic cancer	4/45	83/7206	0.00170261059716
ko04657	IL-17 signaling pathway	4/45	87/7206	0.00202530204065
ko04623	Cytosolic DNA-sensing pathway	3/45	41/7206	0.00205546476967
ko05120	Epithelial cell signaling in Helicobacter pylori infection	4/45	92/7206	0.00248540353501
ko04722	Neurotrophin signaling pathway	5/45	160/7206	0.00302382355073
ko04215	Apoptosis - multiple species	3/45	47/7206	0.00304605366802
ko01521	EGFR tyrosine kinase inhibitor resistance	4/45	106/7206	0.00414743145285
ko04930	Type II diabetes mellitus	3/45	54/7206	0.00452000364039
ko04660	T cell receptor signaling pathway	4/45	124/7206	0.00722038636601
ko05223	Non-small cell lung cancer	3/45	66/7206	0.00791612870451
ko05142	Chagas disease (American trypanosomiasis)	4/45	130/7206	0.00850894535751
ko05166	HTLV-I infection	6/45	292/7206	0.00904654751562
ko04214	Apoptosis - fly	3/45	72/7206	0.0100528860696
ko05134	Legionellosis	3/45	74/7206	0.010832638918
ko05140	Leishmaniasis	3/45	75/7206	0.0112353420528
ko01524	Platinum drug resistance	3/45	76/7206	0.0116466413367
ko04920	Adipocytokine signaling pathway	3/45	89/7206	0.017788162478
ko04068	FoxO signaling pathway	4/45	167/7206	0.0198219676867
ko05418	Fluid shear stress and atherosclerosis	4/45	173/7206	0.0222492278847
ko04932	Non-alcoholic fatty liver disease (NAFLD)	4/45	182/7206	0.0262203935945
ko04659	Th17 cell differentiation	3/45	106/7206	0.0280883137083
ko05200	Pathways in cancer	7/45	492/7206	0.0313475460406
ko05215	Prostate cancer	3/45	111/7206	0.0316101847569
ko04624	Toll and Imd signaling pathway	2/45	49/7206	0.0372492227908
ko04666	Fc gamma R-mediated phagocytosis	3/45	122/7206	0.0401386589396
ko04066	HIF-1 signaling pathway	3/45	123/7206	0.0409666482182
ko01522	Endocrine resistance	3/45	124/7206	0.0418033323961
ko04915	Estrogen signaling pathway	3/45	131/7206	0.0479016328243